Snacks, PharmD, MPH (@zacrobid) 's Twitter Profile
Snacks, PharmD, MPH

@zacrobid

infectious diseases specialist • emergency med emeritus • 🇳🇴 human 🌈 • health is a human right • stigma kills • views = mine • 🚫 med advice

ID: 2746302264

calendar_today19-08-2014 19:37:36

4,4K Tweet

1,1K Followers

381 Following

🦋doctor doubt🦋 (@reverendofdoubt) 's Twitter Profile Photo

This is a pretty incredible WikiGuidelines on UTIs. Wow—a must-read!!! It's interesting that "male" is no longer defined as a 'complicated UTI'! jamanetwork.com/journals/jaman…

JAMA Network Open (@jamanetworkopen) 's Twitter Profile Photo

Most viewed in the last 7 days from JAMA Network Open: This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections (UTIs). ja.ma/4gmFZ19

Most viewed in the last 7 days from <a href="/JAMANetworkOpen/">JAMA Network Open</a>: 

This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections (UTIs). 

ja.ma/4gmFZ19
WikiGuidelines (@wiki_guidelines) 's Twitter Profile Photo

UTI WikiGuideline remains most viewed in the last 7 days from JAMA Network Open. Teamwork makes the dream work 👍Congratulations to everyone who contributed!

UTI WikiGuideline remains most viewed in the last 7 days from <a href="/JAMANetworkOpen/">JAMA Network Open</a>. Teamwork makes the dream work 👍Congratulations to everyone who contributed!
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@absteward) 's Twitter Profile Photo

🔥🔥 NEW 🔥🔥 Year In Review: Top Infectious Diseases Articles From 2024 Our new post, a great collaboration with my friend 🌟 Bug Pharmacist 💊🧫 Tim Gauthier 1️⃣6️⃣⚡️🆔 RCTs JAMA The Lancet ✨ 7️⃣Syst Reviews/Meta 3️⃣🌏Guidelines WikiGuidelines ✨️ #idxposts idstewardship.com/year-review-to…

Infectious Disease News (@infectdisnews) 's Twitter Profile Photo

🧪 New guidance on #STIs, #HIV and #UTIs showed progress in 2024 on treatment and testing of a range of infections. #syphilis #doxyPEP #COVID19 #IDtwitter #MEDtwitter Our rundown of the year's biggest stories on clinical guidance 👇 healio.com/news/infectiou…

Snacks, PharmD, MPH (@zacrobid) 's Twitter Profile Photo

The number of bots in the replies talking about how Sam Darnold is a CHRISTIAN man is outrageous. One step closer to closing the door on Twitter…

CIDRAP (@cidrap) 's Twitter Profile Photo

Antibiotic stewardship, data, and uncertainty: A conversation with Brad Spellberg The longtime stewardship advocate shares his thoughts on shorter antibiotic durations, clinical care guidelines, and the antibiotic pipeline. cidrap.umn.edu/antimicrobial-…

Antibiotic stewardship, data, and uncertainty: A conversation with Brad Spellberg

The longtime stewardship advocate shares his thoughts on shorter antibiotic durations, clinical care guidelines, and the antibiotic pipeline. 

cidrap.umn.edu/antimicrobial-…
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

In this large multi-hospital cohort, the implementation of a blended dosing method using a majority of AUC-based dosing reduced cumulative vancomycin doses, serum levels, and AKI. buff.ly/nYIqxWd

In this large multi-hospital cohort, the implementation of a blended dosing method using a majority of AUC-based dosing reduced cumulative vancomycin doses, serum levels, and AKI. buff.ly/nYIqxWd
Snacks, PharmD, MPH (@zacrobid) 's Twitter Profile Photo

Our real world study is the 1st (to our knowledge) to detail widespread restriction of remdesivir with patients that represent present-day epidemiology in the era of near universal SARS-CoV-2 seropositivity. In CID 📖 Brent Footer Betsy Hirsch, PharmD (TTIDPD) #IDTwitter academic.oup.com/cid/advance-ar…

CIDRAP (@cidrap) 's Twitter Profile Photo

#COVID patients who don't receive remdesivir not more likely to die, data suggest Models found no difference in all-cause death rates, 30-day hospital readmissions, or length of stay before and after restrictions were put into place. cidrap.umn.edu/covid-19/covid…

#COVID patients who don't receive remdesivir not more likely to die, data suggest

Models found no difference in all-cause death rates, 30-day hospital readmissions, or length of stay before and after restrictions were put into place.

cidrap.umn.edu/covid-19/covid…